Looming regulations and FDA oversight mean an uncertain reimbursement climate in 2016.
Rina
R
Wolf
D019411:Clinical Laboratory Techniques / Q000592:standards*; D033161:Government Regulation; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration